MDxHealth Reports Q3 2026 Earnings and Sales Disruptions

MDxHealth SA released its financial results for the third quarter of 2026, with leadership acknowledging that the period's performance missed internal targets. Chief Executive Officer Michael McGarrity and Interim Chief Financial Officer Ron Kalfus hosted the earnings conference call alongside representatives from various financial institutions.

According to the executive team, the shortfall stemmed from temporary disruptions in commercial execution. Specifically, the company experienced accelerated turnover within its sales organization. This staffing shift followed the discontinuation of Resolve and was further impacted by aggressive market targeting from competitors.

Despite the headwinds, executives emphasized that the firm remains committed to operating discipline, transparency, and core principles of focus, execution, and growth. The company continues to navigate regulatory and operational disclosures as outlined in its filings with the Securities and Exchange Commission.

What to watch next: Monitor the company's ability to stabilize its sales workforce and recover commercial momentum in upcoming quarters.